Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Jun 1;77(6):1843-1845.
doi: 10.1097/HEP.0000000000000327. Epub 2023 Feb 6.

Hepatic steatosis provides the terroir that promotes the development of cardiovascular risk factors and disease

Ian A Rowe  1 , Alina M Allen  2
Affiliations
Comment

Hepatic steatosis provides the terroir that promotes the development of cardiovascular risk factors and disease

Ian A Rowe et al. Hepatology. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Allen AM, Therneau TM, Ahmed OT, Gidener T, Mara KC, Larson JJ, et al. Clinical course of non-alcoholic fatty liver disease and the implications for clinical trial design. J Hepatol. 2022;77:1237–45.
    1. Mantovani A, Csermely A, Petracca G, Beatrice G, Corey KE, Simon TG, et al. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021;6:903–13.
    1. Alexander M, Katrina Loomis A, van der Lei J, Duarte-Salles T, Prieto-Alhambra D, Ansell D, et al. Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults. BMJ. 2019;367. Accessed January 3, 2023. https://www.bmj.com/content/367/bmj.l5367
    1. Ahmed HS, Wang N, Carr JJ, Ding J, Terry JG, VanWagner LB, et al. The association between hepatic steatosis and incident cardiovascular disease, cancer, and all-cause mortality in a US multi-cohort study. Hepatology. 2023. doi: 10.1097/HEP.0000000000000286 - DOI
    1. Haneuse S, VanderWeele TJ, Arterburn D. Using the E-value to assess the potential effect of unmeasured confounding in observational studies. JAMA. 2019;321:602–3.

Associated data